Beauchamp v. New York City Tr. Auth.: Future Medical Expenses Must Track Reasonably Certain Proof; Speculative Procedures Cannot Inflate Damages; Remittitur Benchmarks for Extraordinary Injuries

1. Introduction

Beauchamp v New York City Tr. Auth. arises from a March 6, 2017 Manhattan crosswalk collision in which a left-turning bus struck and dragged Aurora Beauchamp, pinning her under a tire for approximately 20 minutes. Defendants conceded liability, leaving damages as the only trial issue, including Aurora’s personal-injury damages and her husband Saul’s loss-of-consortium (loss of services) claim.

The central appellate questions were not whether the injuries were catastrophic—they were—but (i) whether the jury’s pain-and-suffering and consortium awards were excessive under comparative New York precedent, and (ii) whether the jury could award future medical expenses beyond the amount established by expert proof and requested in summation, particularly by implicitly adding costs for procedures that expert testimony characterized as inadvisable and uncertain.

2. Summary of the Opinion

The First Department modified the judgment in three key ways:

• Future medical expenses reduced from $8.5 million to $8,238,345, the precise figure established by plaintiffs’ experts and requested by counsel, because future medical damages must be proven with reasonable certainty and should not include uncertain procedures.
• Pain and suffering and loss-of-services awards vacated and the matter remanded for a new trial on those damages unless plaintiffs stipulate to substantial reductions (remittitur):
  • Aurora: past pain and suffering reduced to $20,000,000 (from $25,000,000)
  • Aurora: future pain and suffering reduced to $17,000,000 (from $32,000,000)
  • Saul: past loss of services reduced to $1,500,000 (from $3,000,000)
  • Saul: future loss of services reduced to $1,100,000 (from $4,000,000)
• The court emphasized that, even at these reduced levels, the overall recovery is extraordinarily large, but not “manifestly excessive” in light of the unique and devastating injuries shown at trial.

3. Analysis

3.1. Precedents Cited

Donlon v City of New York (284 AD2d 13 [1st Dept 2001])

Plaintiffs relied on Donlon v City of New York to argue that comparable awards were scarce and that meaningful comparisons may be difficult. The First Department acknowledged the difficulty of placing a dollar figure on profound human suffering, but used that acknowledgement to pivot to its core point: despite imperfect analogies, there is still precedent sufficient to guide appellate review of excessiveness.

Yvonne Y. v City of New York (199 AD3d 551 [1st Dept 2021]); Gregware v City of New York (132 AD3d 51 [1st Dept 2015]); Aguilar v New York City Tr. Auth. (81 AD3d 509 [1st Dept 2011])

The court cited these cases as examples of precedent used to calibrate pain-and-suffering awards. The decision does not treat them as one-to-one comparators; rather, they function as reference points confirming that appellate courts can and should anchor remittitur in New York’s body of verdict review, even when the plaintiff’s clinical picture is unusually complex.

Importantly, the panel did not suggest that these authorities “cap” awards; instead, it used them to support the proposition that the jury’s numbers were excessive to the extent indicated, and that reduced figures better align with the state’s comparative approach.

Lewis v Ganesh (242 AD3d 548 [1st Dept 2025])

Lewis v Ganesh is the opinion’s key evidentiary anchor on future medical damages. The First Department quoted and applied Lewis to reiterate that future medical expenses must be established “with the requisite degree of reasonable certainty” through expert testimony identifying:

• each treatment the plaintiff will require,
• why it will be required, and
• an approximation of cost.

Here, plaintiffs met that burden—but only for $8,238,345. The jury exceeded that figure, and the appellate court corrected the award to match the amount supported by the record.

Wynter v Transdev Services, Inc. (207 AD3d 785 [2d Dept 2022])

Defendants urged reliance on Wynter v Transdev Services, Inc. as a benchmark. The First Department distinguished it on two levels:

• Procedurally, in Wynter (and Gregware), the Appellate Division rejected a requested decrease, meaning the cases did not necessarily identify a “fully compensatory” ceiling.
• Factually, the plaintiffs in those cases were walking by trial, while Aurora “may never walk unaided,” reducing the value of the comparison.

The takeaway is methodological: comparators must be scrutinized not only for injury labels, but for functional outcomes and trial posture (whether the appellate court actually set a reduced number, or merely declined to disturb one).

Matter of Steam Pipe Explosion at 41st St. & Lexington Ave. (147 AD3d 421 [1st Dept 2017])

Defendants highlighted Matter of Steam Pipe Explosion at 41st St. & Lexington Ave. as a case where the First Department reduced a jury award. The panel distinguished it on a functional-independence axis: by trial, that plaintiff lived independently and performed activities of daily living, whereas Aurora could not “even aspire to” such independence. This distinction reinforced the court’s conclusion that extremely high awards can be justified where long-term dependence, escalating pain, and compounding medical risks are proven.

3.2. Legal Reasoning

(a) Remittitur and excessiveness review

The court applied the familiar New York appellate function of reviewing whether a verdict is excessive in light of comparable cases and the evidence of injury and suffering. The court’s remedy—vacatur of the awards and a new trial unless a stipulation to reduction is filed—reflects classic remittitur practice: the appellate court identifies amounts it deems the highest sustainable figures supported by the record and precedent, leaving plaintiffs the choice between accepting them or retrying damages.

While the court acknowledged the award would remain “substantial” and possibly among the largest approved by an Appellate Division, it emphasized that the reduced totals were reasonable compensation given:

• the lumbosacral plexus avulsion and near-paralysis/insensation of a leg,
• unremitting severe pain (often described as 8–10/10),
• CRPS and the inability to pursue certain pain interventions due to infection risk,
• nonhealing degloving injury with recurrent infections and hospitalizations,
• regression in function after hospitalizations, and
• serious psychological injury including PTSD and suicidal ideation.

(b) Future medical expenses: “reasonable certainty” operates as a ceiling as well as a threshold

The most concrete doctrinal move in the opinion is the treatment of future medical expenses. Plaintiffs proved a specific future-care plan costed at $8,238,345, and the jury could credit it. But the jury could not go beyond it without evidentiary support meeting the same “reasonable certainty” standard.

Plaintiffs attempted to justify the extra amount by pointing to possible costs of a spinal cord stimulator and total hip replacement. The court rejected that rationale because the record also contained testimony that those procedures were “ill advised” due to high infection risk and were therefore “by no means certain to ever be performed.”

Practically, the opinion confirms two constraints:

• Speculative or medically contraindicated interventions cannot be used to inflate a future-medical award absent proof they are reasonably certain to occur.
• Where the only quantified, supported figure is a specific life-care total, the award should not exceed it on the theory that “something else might be needed.”

3.3. Impact

For future medical damages proof

Beauchamp strengthens a disciplined approach to life-care proof: future medical awards should mirror what experts actually cost out with reasonable certainty, and litigants should expect appellate correction where juries “round up” beyond the proven plan. It also signals that defendants can effectively attack “add-ons” by emphasizing medical uncertainty, contraindications, and lack of quantified support.

For extraordinary injury valuations

The decision is also notable for how it treats “record-setting” awards: it does not reject them because of size alone. Instead, it frames the task as matching amounts to functional devastation, chronicity, treatment limits, and psychological harm—while still using comparative precedent to guard against excess.

For consortium (loss of services) claims

By vacating and remitting Saul’s awards despite “unrebutted evidence” of life alteration, the court signals that consortium damages remain subject to the same comparative excessiveness discipline as primary personal-injury damages, particularly when the numbers appear disproportionate to established ranges in precedent.

4. Complex Concepts Simplified

• Remittitur: An appellate remedy allowing a plaintiff to accept a reduced amount the appellate court finds supportable; otherwise, a new trial is ordered on damages.
• Future medical expenses proven with “reasonable certainty”: The plaintiff must show, usually through expert testimony, that specific future treatments are likely needed and provide a reliable cost estimate. Possibilities and contingencies are not enough.
• Loss of services / loss of consortium: Damages awarded to a spouse for the loss of companionship, affection, and the practical benefits of the marital relationship due to the injured spouse’s condition.
• CRPS (complex regional pain syndrome): A chronic pain condition that can cause severe, disproportionate pain and hypersensitivity, sometimes limiting even basic care because touch itself can be painful.
• Degloving injury: A severe soft-tissue injury where skin and tissue are torn away, often creating chronic wounds and infection risk.

5. Conclusion

Beauchamp v New York City Tr. Auth. delivers two practical appellate lessons. First, even in uniquely catastrophic cases, the First Department will apply comparative precedent to correct excessive pain-and-suffering and consortium awards through remittitur. Second—and most clearly—future medical expenses must be tethered to expert proof establishing need and cost with reasonable certainty; juries may not add amounts for interventions that are medically inadvisable or not reasonably certain to occur. The opinion thus both preserves the possibility of exceptionally high damages for exceptional injuries and reinforces evidentiary rigor as the controlling constraint on future-care awards.